Close Menu

NEW YORK – Eurobio Scientific said on Tuesday that it has received CE marking for its EBX 042 FluCoSyn test, which can identify viruses for the main flu-like symptoms.

The Paris-based firm said the RT-PCR assay can be used to test for SARS-CoV-2, influenza A and B, and respiratory syncytial virus from one patient sample. More specifically, the multiplex kit has five targets, the R and N genes for SARS-CoV-2; one common target for influenza A and B; one target for RSV; and one target for the control integrated into each test to validate the correct functioning of the reaction.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.